Cargando…

Erythema Multiforme Major following SARS‐CoV‐2 vaccine

Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2. Correct patient history collection allows prompt recognition and subsequent successful me...

Descripción completa

Detalles Bibliográficos
Autores principales: Saibene, Alberto Maria, Alliata, Andrea, Cozzi, Anna Teresa, Ottavi, Alice, Spagnolini, Sofia, Pipolo, Carlotta, Maccari, Alberto, Felisati, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512181/
https://www.ncbi.nlm.nih.gov/pubmed/34667612
http://dx.doi.org/10.1002/ccr3.4947
_version_ 1784582929192583168
author Saibene, Alberto Maria
Alliata, Andrea
Cozzi, Anna Teresa
Ottavi, Alice
Spagnolini, Sofia
Pipolo, Carlotta
Maccari, Alberto
Felisati, Giovanni
author_facet Saibene, Alberto Maria
Alliata, Andrea
Cozzi, Anna Teresa
Ottavi, Alice
Spagnolini, Sofia
Pipolo, Carlotta
Maccari, Alberto
Felisati, Giovanni
author_sort Saibene, Alberto Maria
collection PubMed
description Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2. Correct patient history collection allows prompt recognition and subsequent successful medical management with oral corticosteroids.
format Online
Article
Text
id pubmed-8512181
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85121812021-10-18 Erythema Multiforme Major following SARS‐CoV‐2 vaccine Saibene, Alberto Maria Alliata, Andrea Cozzi, Anna Teresa Ottavi, Alice Spagnolini, Sofia Pipolo, Carlotta Maccari, Alberto Felisati, Giovanni Clin Case Rep Case Report Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2. Correct patient history collection allows prompt recognition and subsequent successful medical management with oral corticosteroids. John Wiley and Sons Inc. 2021-10-13 /pmc/articles/PMC8512181/ /pubmed/34667612 http://dx.doi.org/10.1002/ccr3.4947 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Saibene, Alberto Maria
Alliata, Andrea
Cozzi, Anna Teresa
Ottavi, Alice
Spagnolini, Sofia
Pipolo, Carlotta
Maccari, Alberto
Felisati, Giovanni
Erythema Multiforme Major following SARS‐CoV‐2 vaccine
title Erythema Multiforme Major following SARS‐CoV‐2 vaccine
title_full Erythema Multiforme Major following SARS‐CoV‐2 vaccine
title_fullStr Erythema Multiforme Major following SARS‐CoV‐2 vaccine
title_full_unstemmed Erythema Multiforme Major following SARS‐CoV‐2 vaccine
title_short Erythema Multiforme Major following SARS‐CoV‐2 vaccine
title_sort erythema multiforme major following sars‐cov‐2 vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512181/
https://www.ncbi.nlm.nih.gov/pubmed/34667612
http://dx.doi.org/10.1002/ccr3.4947
work_keys_str_mv AT saibenealbertomaria erythemamultiformemajorfollowingsarscov2vaccine
AT alliataandrea erythemamultiformemajorfollowingsarscov2vaccine
AT cozziannateresa erythemamultiformemajorfollowingsarscov2vaccine
AT ottavialice erythemamultiformemajorfollowingsarscov2vaccine
AT spagnolinisofia erythemamultiformemajorfollowingsarscov2vaccine
AT pipolocarlotta erythemamultiformemajorfollowingsarscov2vaccine
AT maccarialberto erythemamultiformemajorfollowingsarscov2vaccine
AT felisatigiovanni erythemamultiformemajorfollowingsarscov2vaccine